tiprankstipranks
Agilent (CH:AG8)
:AG8
Switzerland Market
AG8
Agilent
RESEARCH TOOLSreports

Agilent (AG8) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

AG8 Analyst Ratings

Strong Buy
16Ratings
Strong Buy
13 Buy
3 Hold
0 Sell
Based on 16 analysts giving stock ratings to
Agilent
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AG8 Stock 12 Month Forecast

Average Price Target

―
Based on 16 Wall Street analysts offering 12 month price targets for Agilent in the last 3 months. The average price target is CHF125.45 with a high forecast of CHF145.56 and a low forecast of CHF109.17. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF145.56Average Price TargetCHF125.45Lowest Price TargetCHF109.17
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CH:AG8
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
CHF129.39
Buy
―
Reiterated
08/05/26
Morgan Stanley Keeps Their Buy Rating on Agilent (A)
Bernstein Analyst forecast on CH:AG8
Eve Burstein
Bernstein
Bernstein
CHF125.35
Buy
―
Reiterated
07/22/26
Bernstein Sticks to Its Buy Rating for Agilent (A)
Jefferies Analyst forecast on CH:AG8
Tycho Peterson
Jefferies
Jefferies
CHF109.17
Hold
―
Initiated
07/09/26
Analysts Are Neutral on These Healthcare Stocks: LENZ Therapeutics (LENZ), Agilent (A)
Evercore ISI Analyst forecast on CH:AG8
Vijay Kumar
Evercore ISI
Evercore ISI
CHF116.45→CHF119.69
Buy
―
Reiterated
07/06/26
Agilent price target raised to $148 from $144 at Evercore ISIAgilent price target raised to $148 from $144 at Evercore ISI
Barclays Analyst forecast on CH:AG8
Luke Sergott
Barclays
Barclays
CHF117.26→CHF121.3
Buy
―
Assigned
06/24/26
Barclays Sticks to Its Buy Rating for Agilent (A)
Piper Sandler Analyst forecast on CH:AG8
David Westenberg
Piper Sandler
Piper Sandler
CHF121.3
Hold
―
Initiated
06/11/26
Agilent initiated with a Neutral at Piper SandlerAgilent initiated with a Neutral at Piper Sandler
HSBC Analyst forecast on CH:AG8
Sidharth Sahoo
HSBC
HSBC
CHF145.56→CHF133.43
Buy
―
Reiterated
06/03/26
Agilent price target lowered to $165 from $180 at HSBCAgilent price target lowered to $165 from $180 at HSBC
Bank of America Securities Analyst forecast on CH:AG8
Michael Ryskin
Bank of America Securities
Bank of America Securities
CHF117.26→CHF125.35
Buy
―
Reiterated
06/02/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wolfe Research Analyst forecast on CH:AG8
Michael Polark
Wolfe Research
Wolfe Research
CHF109.17
Hold
―
Initiated
06/01/26
Agilent initiated with a Peer Perform at Wolfe ResearchAgilent initiated with a Peer Perform at Wolfe Research
Wells Fargo Analyst forecast on CH:AG8
Brandon Couillard
Wells Fargo
Wells Fargo
CHF133.43→CHF129.39
Buy
―
Reiterated
05/28/26
Agilent price target lowered to $160 from $165 at Wells FargoAgilent price target lowered to $160 from $165 at Wells Fargo
Stifel Nicolaus Analyst forecast on CH:AG8
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
CHF137.48
Buy
―
Reiterated
05/28/26
Analysts Offer Insights on Healthcare Companies: Quanterix (NASDAQ: QTRX), Bio-Techne (NASDAQ: TECH) and Agilent (NYSE: A)
TD Cowen Analyst forecast on CH:AG8
Daniel Brennan
TD Cowen
TD Cowen
CHF126.96→CHF125.35
Buy
―
Reiterated
05/27/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (NYSE: PHR), Agilent (NYSE: A) and Pfizer (NYSE: PFE)
J.P. Morgan Analyst forecast on CH:AG8
Casey Woodring
J.P. Morgan
J.P. Morgan
CHF145.56
Buy
―
Reiterated
05/27/26
Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A), Apogee Therapeutics (NASDAQ: APGE) and Pfizer (NYSE: PFE)
Goldman Sachs Analyst forecast on CH:AG8
Evie Koslosky
Goldman Sachs
Goldman Sachs
CHF121.3→CHF125.35
Buy
―
Reiterated
05/27/26
Goldman Sachs Reaffirms Their Buy Rating on Agilent (A)
RBC Capital Analyst forecast on CH:AG8
Dan Leonard
RBC Capital
RBC Capital
CHF123.73
Buy
―
Reiterated
05/26/26
Agilent initiated with an Outperform at RBC CapitalAgilent initiated with an Outperform at RBC Capital
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CH:AG8
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
CHF129.39
Buy
―
Reiterated
08/05/26
Morgan Stanley Keeps Their Buy Rating on Agilent (A)
Bernstein Analyst forecast on CH:AG8
Eve Burstein
Bernstein
Bernstein
CHF125.35
Buy
―
Reiterated
07/22/26
Bernstein Sticks to Its Buy Rating for Agilent (A)
Jefferies Analyst forecast on CH:AG8
Tycho Peterson
Jefferies
Jefferies
CHF109.17
Hold
―
Initiated
07/09/26
Analysts Are Neutral on These Healthcare Stocks: LENZ Therapeutics (LENZ), Agilent (A)
Evercore ISI Analyst forecast on CH:AG8
Vijay Kumar
Evercore ISI
Evercore ISI
CHF116.45→CHF119.69
Buy
―
Reiterated
07/06/26
Agilent price target raised to $148 from $144 at Evercore ISIAgilent price target raised to $148 from $144 at Evercore ISI
Barclays Analyst forecast on CH:AG8
Luke Sergott
Barclays
Barclays
CHF117.26→CHF121.3
Buy
―
Assigned
06/24/26
Barclays Sticks to Its Buy Rating for Agilent (A)
Piper Sandler Analyst forecast on CH:AG8
David Westenberg
Piper Sandler
Piper Sandler
CHF121.3
Hold
―
Initiated
06/11/26
Agilent initiated with a Neutral at Piper SandlerAgilent initiated with a Neutral at Piper Sandler
HSBC Analyst forecast on CH:AG8
Sidharth Sahoo
HSBC
HSBC
CHF145.56→CHF133.43
Buy
―
Reiterated
06/03/26
Agilent price target lowered to $165 from $180 at HSBCAgilent price target lowered to $165 from $180 at HSBC
Bank of America Securities Analyst forecast on CH:AG8
Michael Ryskin
Bank of America Securities
Bank of America Securities
CHF117.26→CHF125.35
Buy
―
Reiterated
06/02/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wolfe Research Analyst forecast on CH:AG8
Michael Polark
Wolfe Research
Wolfe Research
CHF109.17
Hold
―
Initiated
06/01/26
Agilent initiated with a Peer Perform at Wolfe ResearchAgilent initiated with a Peer Perform at Wolfe Research
Wells Fargo Analyst forecast on CH:AG8
Brandon Couillard
Wells Fargo
Wells Fargo
CHF133.43→CHF129.39
Buy
―
Reiterated
05/28/26
Agilent price target lowered to $160 from $165 at Wells FargoAgilent price target lowered to $160 from $165 at Wells Fargo
Stifel Nicolaus Analyst forecast on CH:AG8
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
CHF137.48
Buy
―
Reiterated
05/28/26
Analysts Offer Insights on Healthcare Companies: Quanterix (NASDAQ: QTRX), Bio-Techne (NASDAQ: TECH) and Agilent (NYSE: A)
TD Cowen Analyst forecast on CH:AG8
Daniel Brennan
TD Cowen
TD Cowen
CHF126.96→CHF125.35
Buy
―
Reiterated
05/27/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (NYSE: PHR), Agilent (NYSE: A) and Pfizer (NYSE: PFE)
J.P. Morgan Analyst forecast on CH:AG8
Casey Woodring
J.P. Morgan
J.P. Morgan
CHF145.56
Buy
―
Reiterated
05/27/26
Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A), Apogee Therapeutics (NASDAQ: APGE) and Pfizer (NYSE: PFE)
Goldman Sachs Analyst forecast on CH:AG8
Evie Koslosky
Goldman Sachs
Goldman Sachs
CHF121.3→CHF125.35
Buy
―
Reiterated
05/27/26
Goldman Sachs Reaffirms Their Buy Rating on Agilent (A)
RBC Capital Analyst forecast on CH:AG8
Dan Leonard
RBC Capital
RBC Capital
CHF123.73
Buy
―
Reiterated
05/26/26
Agilent initiated with an Outperform at RBC CapitalAgilent initiated with an Outperform at RBC Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Agilent

3 Months
Dan LeonardRBC Capital
Success Rate
18/27 ratings generated profit
67%
Average Return
+4.73%
Copying Dan Leonard's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +4.73% per trade.
1 Year
Brandon CouillardWells Fargo
Success Rate
33/42 ratings generated profit
79%
Average Return
+17.35%
Copying Brandon Couillard's trades and holding each position for 1 Year would result in 78.57% of your transactions generating a profit, with an average return of +17.35% per trade.
2 Years
Puneet SoudaLeerink Partners
Success Rate
17/23 ratings generated profit
74%
Average Return
+7.63%
Copying Puneet Souda's trades and holding each position for 2 Years would result in 73.91% of your transactions generating a profit, with an average return of +7.63% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AG8 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
2
2
2
2
1
Buy
16
15
15
15
7
Hold
1
0
2
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
17
19
20
11
In the current month, AG8 has received 8 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. AG8 average Analyst price target in the past 3 months is 125.45.
Each month's total comprises the sum of three months' worth of ratings.

AG8 Financial Forecast

AG8 Earnings Forecast

Next quarter’s earnings estimate for AG8 is CHF1.20 with a range of CHF1.16 to CHF1.21. The previous quarter’s EPS was CHF1.20. AG8 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year AG8 has Performed in-line its overall industry.
Next quarter’s earnings estimate for AG8 is CHF1.20 with a range of CHF1.16 to CHF1.21. The previous quarter’s EPS was CHF1.20. AG8 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year AG8 has Performed in-line its overall industry.

AG8 Sales Forecast

Next quarter’s sales forecast for AG8 is CHF1.49B with a range of CHF1.48B to CHF1.50B. The previous quarter’s sales results were CHF1.48B. AG8 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year AG8 has Performed in-line its overall industry.
Next quarter’s sales forecast for AG8 is CHF1.49B with a range of CHF1.48B to CHF1.50B. The previous quarter’s sales results were CHF1.48B. AG8 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year AG8 has Performed in-line its overall industry.

AG8 Stock Forecast FAQ

What is CH:AG8’s average 12-month price target, according to analysts?
Based on analyst ratings, Agilent’s 12-month average price target is 125.45.
    What is CH:AG8’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:AG8, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Agilent a Buy, Sell or Hold?
        Agilent has a consensus rating of Strong Buy, which is based on 13 buy ratings, 3 hold ratings and 0 sell ratings.
          What is Agilent’s share price target?
          The average share price target for Agilent is 125.45. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF145.56 ,and the lowest forecast is CHF109.17. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Agilent?
            Agilent’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
              How can I buy shares of Agilent?
              To buy shares of CH:AG8, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.